OvaScience Inc (OVAS)

7.16
0.07 0.97
NASDAQ : Health Care
Prev Close 7.23
Open 7.26
Day Low/High 6.96 / 7.30
52 Wk Low/High 4.53 / 31.72
Volume 647.76K
Avg Volume 372.40K
Exchange NASDAQ
Shares Outstanding 35.56M
Market Cap 278.80M
EPS -2.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

OvaScience To Present At Upcoming Investor Conferences In September

OvaScience To Present At Upcoming Investor Conferences In September

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Harald Stock, Ph.

OvaScience's AUGMENT Treatment Commercially Available In Japan Through Partnership With IVF JAPAN GROUP

OvaScience's AUGMENT Treatment Commercially Available In Japan Through Partnership With IVF JAPAN GROUP

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that it has finalized its commercial agreement with the IVF...

OvaScience Reports Second Quarter 2016 Financial Results

OvaScience Reports Second Quarter 2016 Financial Results

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported its second quarter 2016 financial results and highlighted recent...

OvaScience To Host Second Quarter 2016 Financial Results Conference Call

OvaScience To Host Second Quarter 2016 Financial Results Conference Call

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.

OvaScience (OVAS) Weak On High Volume Today

OvaScience (OVAS) Weak On High Volume Today

Trade-Ideas LLC identified OvaScience (OVAS) as a weak on high relative volume candidate

Harald Stock, Ph.D. Commences Role As President And Chief Executive Officer Of OvaScience

Harald Stock, Ph.D. Commences Role As President And Chief Executive Officer Of OvaScience

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Harald F.

OvaScience To Present At The JMP Securities Life Sciences Conference

OvaScience To Present At The JMP Securities Life Sciences Conference

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that Company management will present at the JMP Securities Life...

OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced the grant of an inducement award to its newly appointed...

OvaScience Announces Closing Of Public Offering Of Common Stock

OvaScience Announces Closing Of Public Offering Of Common Stock

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced the closing of its previously announced public offering,...

Ovascience (OVAS) Stock Drops After Pricing Public Offering

Ovascience (OVAS) Stock Drops After Pricing Public Offering

Ovascience (OVAS) stock is tanking in late-morning trading after the company priced a public offering of common shares at a steep discount.

Ovascience May Be Hard-Pressed to Overcome Market Skepticism

Ovascience May Be Hard-Pressed to Overcome Market Skepticism

Prospects for the company's fertility drug may not be strong enough to offset dilution from its new stock offering.

OvaScience Announces Pricing Of Public Offering Of Common Stock

OvaScience Announces Pricing Of Public Offering Of Common Stock

OvaScience SMĀ (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it has priced its previously announced underwritten...

OvaScience Announces Proposed Public Offering Of Common Stock

OvaScience Announces Proposed Public Offering Of Common Stock

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it has commenced an underwritten public offering of shares...

OvaScience (OVAS) Is Strong On High Volume Today

OvaScience (OVAS) Is Strong On High Volume Today

Trade-Ideas LLC identified OvaScience (OVAS) as a strong on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BTG, CSPI, CTRE, FFIV, IBP, MON, NMFC, SRC Downgrades: AIRM, COHU, GPX, KSS Initiations: OVAS, TRVN Read on to get TheStreet Quant Ratings' detailed report:

OvaScience Reports First Quarter 2016 Financial Results

OvaScience Reports First Quarter 2016 Financial Results

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported its first quarter 2016 financial results and highlighted recent...

OvaScience To Host First Quarter 2016 Financial Results Conference Call

OvaScience To Host First Quarter 2016 Financial Results Conference Call

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.

Commit To Buy OvaScience At $7.50, Earn 26.4% Annualized Using Options

Commit To Buy OvaScience At $7.50, Earn 26.4% Annualized Using Options

Investors considering a purchase of OvaScience Inc. stock, but cautious about paying the going market price of $10.00/share, might benefit from considering selling puts among the alternative strategies at their disposal.

OvaScience Announces Senior Management Changes And Appointments

OvaScience Announces Senior Management Changes And Appointments

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Arthur Tzianabos, Ph.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Credit Suisse's 12 Contrarian Stock Ideas to Sell Now

Credit Suisse's 12 Contrarian Stock Ideas to Sell Now

Credit Suisse is even more pessimistic than Wall Street on these 12 stocks. The Swiss investment bank rates all of the stocks at sell. Find out why.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today the grant of inducement awards to its newly appointed Chief...

OVAS: Insiders vs. Shorts

OVAS: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 02/12/2016 settlement date, and OvaScience Inc. is one of the most shorted stocks of the Russell 3000, based on 14.65 "days to cover" versus the median component at 5.27.

OvaScience To Present At Cowen And Company Health Care Conference

OvaScience To Present At Cowen And Company Health Care Conference

OvaScience SM (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that Company management will present at the Cowen and Company...

OvaScience Reports Fourth Quarter And Year-End 2015 Financial Results

OvaScience Reports Fourth Quarter And Year-End 2015 Financial Results

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported fourth quarter and year end 2015 financial results.

OvaScience Appoints Paul W.D. Chapman To Chief Operating Officer

OvaScience Appoints Paul W.D. Chapman To Chief Operating Officer

OvaScience SM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced Paul W.